Drug Resistance Patterns and Pathogen Distribution in Patients with Urinary Tract Infection in Suzhou, China: A Five-Year Retrospective Study (2020–2024)

  30 January 2026

This five-year analysis of 9,249 positive urine cultures from UTI patients in Suzhou, China (2020–2024) found that infections predominantly affected women and older adults, with Escherichia coli as the leading pathogen, followed by Enterococcus faecalis, Klebsiella pneumoniae, and Enterococcus faecium. While E. coli showed a significant decline in resistance to third- and fourth-generation cephalosporins and a reduced prevalence of ESBL producers, resistance to fluoroquinolones remained persistently high. Of particular concern were marked fluctuations in carbapenem resistance in K. pneumoniae, peaking at over 40%, and the extreme, species-specific resistance of E. faecium to ampicillin and fluoroquinolones, which severely constrained treatment options. Among fungal pathogens, azole resistance decreased in Candida albicans but remained high in Candida tropicalis. Overall, the dynamic shifts in pathogen distribution and resistance patterns highlight the need for continuous local surveillance, refined empirical therapy, and strengthened antimicrobial stewardship to optimize UTI management.

Further reading: Dovepress
Author(s): Gao J, Wu F, Zhang Y, Wu J, Li W, Su N, Wang Y
Effective Surveillance  
Back

OUR UNDERWRITERS

Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition

INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS

BD





AMR NEWS

Your Biweekly Source for Global AMR Insights!

Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.

Don’t miss out on staying ahead in the global AMR movement—subscribe now!

Subscribe
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!